Reduce heart failure risk tagged posts

Protein in Soy may Reduce the Risk of Heart Failure by Affecting Gut Bacteria

A research team from the Nagoya University Graduate School of Medicine has discovered a promising way to slow the progression of heart failure in mice. They fed mice a diet rich in the soybean protein, β-conglycinin (β-CG), which can support heart health by influencing gut bacteria. Their analysis revealed that the soybean protein rich diet increased the production of the short-chain fatty acids (SCFAs) in the intestine that play a role in protecting the heart. Their findings were published in Clinical Nutrition.

Many people with heart problems try to eat a nutritious diet to reduce their risk of disease. As part of a healthy diet, soybeans have long been recognized for their antioxidant and anti-inflammatory properties...

Read More

Coffee lovers, rejoice! Drinking more coffee associated with Decreased Heart Failure Risk

Image result for Coffee lovers, rejoice! Drinking more coffee associated with Decreased Heart Failure Risk

Circulation: Heart Failure Journal Report..Dietary information from 3 large, well-known heart disease studies suggests drinking one or more cups of caffeinated coffee may reduce heart failure risk, according to research published today in Circulation: Heart Failure, an American Heart Association journal.

Coronary artery disease, heart failure and stroke are among the top causes of death from heart disease in the U.S. “While smoking, age and high blood pressure are among the most well-known heart disease risk factors, unidentified risk factors for heart disease remain,” according to David P. Kao, M.D...

Read More

A Gene that, when working properly Reduces Heart Failure Risk and Improve Rx outcomes

Euan Ashley

Euan Ashley and his colleagues discovered an association between heart failure and a pathway linked to narcolepsy. Mark Tuschman

The gene identified by Stanford researchers codes for a protein first identified when a mutated form was shown to cause narcolepsy.
Caring for patients with heart failure costs the US $40 billion a year. Few new treatments have been developed, and those that exist produce varied responses among patients. One major challenge to the development of new treatments has been the lack of genes that can be confidently associated with heart failure. Prof. Euan Ashley is hopeful that the new finding will open doors to evaluating possible treatments.

orexin (hypocretin) neuropeptide precursor

orexin (hypocretin) neuropeptide precursor

Perez wondered if there were genetic reasons for discrepancies in treatment outcom...

Read More